These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38670070)

  • 21. The Impact of the Microbiome on Resistance to Cancer Treatment with Chemotherapeutic Agents and Immunotherapy.
    Sevcikova A; Izoldova N; Stevurkova V; Kasperova B; Chovanec M; Ciernikova S; Mego M
    Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current status of intratumour microbiome in cancer and engineered exogenous microbiota as a promising therapeutic strategy.
    Chen J; Li T; Liang J; Huang Q; Huang JD; Ke Y; Sun H
    Biomed Pharmacother; 2022 Jan; 145():112443. PubMed ID: 34847476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intratumoral microbiota: implications for cancer onset, progression, and therapy.
    Wu J; Zhang P; Mei W; Zeng C
    Front Immunol; 2023; 14():1301506. PubMed ID: 38292482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
    Hilmi M; Kamal M; Vacher S; Dupain C; Ibadioune S; Halladjian M; Sablin MP; Marret G; Ajgal ZC; Nijnikoff M; Salomon A; El Beaino Z; Servant N; Dureau S; Sokol H; Nicolle R; Le Tourneau C; Bieche I; Neuzillet C
    Eur J Cancer; 2023 Apr; 183():152-161. PubMed ID: 36868056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The intratumoral microbiota: From microniches to single cells.
    Bullman S
    Cell; 2023 Apr; 186(8):1532-1534. PubMed ID: 37059062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The microbiome and human cancer.
    Sepich-Poore GD; Zitvogel L; Straussman R; Hasty J; Wargo JA; Knight R
    Science; 2021 Mar; 371(6536):. PubMed ID: 33766858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The microbiome(s) and cancer: know thy neighbor(s).
    González-Sánchez P; DeNicola GM
    J Pathol; 2021 Jul; 254(4):332-343. PubMed ID: 33723873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compartmentalization of the host microbiome: how tumor microbiota shapes checkpoint immunotherapy outcome and offers therapeutic prospects.
    Boesch M; Horvath L; Baty F; Pircher A; Wolf D; Spahn S; Straussman R; Tilg H; Brutsche MH
    J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36343977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mapping the colorectal tumor microbiota.
    Murphy CL; Barrett M; Pellanda P; Killeen S; McCourt M; Andrews E; O' Riordain M; Shanahan F; O'Toole P
    Gut Microbes; 2021; 13(1):1-10. PubMed ID: 34030582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacteria break barrier to promote metastasis.
    Murota Y; Jobin C
    Cancer Cell; 2021 May; 39(5):598-600. PubMed ID: 33891891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities.
    Wang M; Yu F; Li P
    Front Immunol; 2023; 14():1269054. PubMed ID: 37868956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative Analysis of Human Cancer Cell Extravasation Using Intravital Imaging.
    Willetts L; Bond D; Stoletov K; Lewis JD
    Methods Mol Biol; 2016; 1458():27-37. PubMed ID: 27581012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex interactions between the microbiome and cancer immune therapy.
    Schwartz DJ; Rebeck ON; Dantas G
    Crit Rev Clin Lab Sci; 2019 Dec; 56(8):567-585. PubMed ID: 31526274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
    Rajpoot M; Sharma AK; Sharma A; Gupta GK
    Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.
    Fu A; Yao B; Dong T; Chen Y; Yao J; Liu Y; Li H; Bai H; Liu X; Zhang Y; Wang C; Guo Y; Li N; Cai S
    Cell; 2022 Apr; 185(8):1356-1372.e26. PubMed ID: 35395179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metastasis-related gene identification by compound constrained NMF and a semisupervised cluster approach using pancancer multiomics features.
    Xu Y; Cui X; Zhang L; Zhao T; Wang Y
    Comput Biol Med; 2022 Dec; 151(Pt A):106263. PubMed ID: 36371902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abundance and Metabolism Disruptions of Intratumoral Microbiota by Chemical and Physical Actions Unfreeze Tumor Treatment Resistance.
    Kong F; Fang C; Zhang Y; Duan L; Du D; Xu G; Li X; Li H; Yin Y; Xu H; Zhang K
    Adv Sci (Weinh); 2022 Mar; 9(7):e2105523. PubMed ID: 35037431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intratumoral Bacteria as Mediators of Cancer Immunotherapy Response.
    Sfanos KS
    Cancer Res; 2023 Sep; 83(18):2985-2986. PubMed ID: 37712178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.